Kyto Biopharma
Los Altos Hills, US
Founders & leadership
GB
Georges BenarrochDirector, Executive Officer
Reported raises · per SEC filings
Form D private placements$845KraisedMay 2018 · 11 investors · Other Technology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.